Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer. | Jpn Dent Sci Rev | 2023 | 37680614 | PubTator, text mining | PubMed |
| Distinct N7-methylguanosine profiles of circular RNAs in drug-resistant acute myeloid leukemia. | Sci Rep | 2023 | 37679400 | PubTator, text mining | PubMed |
| A Study in Scaffold Hopping: Discovery and Optimization of Thiazolopyridines as Potent Herbicides That Inhibit Acyl-ACP Thioesterase. | J Agric Food Chem | 2023 | 37677080 | PubTator, text mining | PubMed |
| Effective TME-related signature to predict prognosis of patients with head and neck squamous cell carcinoma. | Front Mol Biosci | 2023 | 37670814 | PubTator, text mining | PubMed |
| [Malignant peripheral nerve sheath tumor: a clinicopathological analysis]. | Zhonghua Bing Li Xue Za Zhi | 2023 | 37670622 | PubTator, text mining | PubMed |
| Genomic and Transcriptomic Landscape of an Oral Squamous Cell Carcinoma Mouse Model for Immunotherapy. | Cancer Immunol Res | 2023 | 37669022 | PubTator, text mining | PubMed |
| FAT4 overexpression promotes antitumor immunity by regulating the β-catenin/STT3/PD-L1 axis in cervical cancer. | J Exp Clin Cancer Res | 2023 | 37658376 | PubTator, text mining | PubMed |
| Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel. | PLoS One | 2023 | 37656691 | PubTator, text mining | PubMed |
| Magnetic resonance imaging techniques for the quantitative analysis of skeletal muscle: State of the art. | J Orthop Translat | 2023 | 37654433 | PubTator, text mining | PubMed |
| Impact of programmed death-ligand 1 (PD-L1) positivity on clinical and molecular features of patients with metastatic gastric cancer. | Cancer Med | 2023 | 37654198 | PubTator, text mining | PubMed |
| Molecular and clonal evolution in vivo reveal a common pathway of distant relapse gliomas. | iScience | 2023 | 37649695 | PubTator, text mining | PubMed |
| Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling. | Br J Haematol | 2023 | 37646306 | PubTator, text mining | PubMed |
| Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment. | J Transl Med | 2023 | 37644433 | PubTator, text mining | PubMed |
| Global comparative transcriptomes uncover novel and population-specific gene expression in esophageal squamous cell carcinoma. | Infect Agent Cancer | 2023 | 37641095 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis reveals that immune cells induce human nucleus pulposus ossification and degeneration. | Front Immunol | 2023 | 37638033 | PubTator, text mining | PubMed |
| Knowledge Translation in Glomerulonephritis: Successes in Translational Research From the Bench to Bedside. | Can J Kidney Health Dis | 2023 | 37637870 | PubTator, text mining | PubMed |
| FAT1 Gene Expression in Iranian Acute Lymphoid and Myeloid Leukemia Patients. | Int J Hematol Oncol Stem Cell Res | 2023 | 37637767 | PubTator, text mining | PubMed |
| Systematic establishment and verification of an epithelial-mesenchymal transition gene signature for predicting prognosis of oral squamous cell carcinoma. | Front Genet | 2023 | 37636263 | PubTator, text mining | PubMed |
| Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer. | Genome Biol | 2023 | 37635261 | PubTator, text mining | PubMed |
| Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends. | Signal Transduct Target Ther | 2023 | 37635168 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=29